2006D-0383
  

  
 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases

  


  

  

  


  

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC2737
  



  

  
Submitter : 
  

  
Ms. Adelaide Sangiorgi
  

  
Date & Time: 
  

  
12/07/2006 11:12:41
  



  

  
Organization : 
  

  
Ms. Adelaide Sangiorgi
  



  

  
Category : 
  

  
Consumer Group
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 In response to FDA Docket 2006D-0383, it is abundantly clear in the FDA guidelines that there are alternative cell lines and technologies that could be

employed for vaccine development other than abortion-derived fetal cell lines.  As a citizen concerned with both moral values and the health of our families, I request government intervention to ensure the creation of vaccines from non-objectionable sources.  It is an unjust coercion of people's consciences when vaccines are needed that utilize aborted fetal cell lines.  Equally, there is a danger that many people would not submit to immunizations produced in this manner, which could endanger the health and protection of the population as 

a whole during an outbreak. Thus, it is in the best interest to the population, as well as pharmaceutical companies and government agencies' responsibility, to promote the use of non-objectionable sources.  Please take these comments under serious consideration.



A concerned citizen, sincerely,



Adelaide Sangiorgi